Monday, August 22, 2016

UPDATE 3-Pfizer boosts cancer drug roster with $14 bln Medivation deal

Aug 22 (Reuters) - Pfizer Inc, beating out numerous

other bidders, said it would buy U.S. cancer drug company

Medivation Inc for $14 billion in cash, adding its

blockbuster prostate cancer drug...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)